Onset of non-AIDS Kaposi sarcoma during therapy with interferon alfa-2a in an 82-year-old man with concomitant cutaneous T-cell lymphoma.
Giuliani
Massimo
M
Mastroianni
Antonio
A
Di Carlo
Aldo
A
Donati
Pietro
P
Miceli
Michelina
M
Monini
Paolo
P
Rezza
Giovanni
G
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D018023:HIV Seronegativity; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D016410:Lymphoma, T-Cell, Cutaneous / Q000139:chemically induced* / Q000188:drug therapy*; D008297:Male; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000139:chemically induced*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins